We are reaching out to inform you that Susan G. Komen’s® call for research proposals from early career investigators Letters of Intent Deadline is Extended to August 1, 2022 1:00 p.m. Eastern Standard Time.
For more than a decade Susan G. Komen Career Catalyst Research (CCR) Grants have fostered promising breast cancer researchers who are in the early stages of their faculty careers, conducting research that has unlocked new knowledge about breast cancer and helped advance patient care. Through this grant mechanism, we seek to support those who will emerge as the next generation of key leaders in the quest to end breast cancer.
Eligibility: Junior faculty members working at academic institutions in the United States who have not held any faculty appointment for more than a total of six years are invited to apply for our Career Catalyst Research Grants.
Funding Level: Up to $450,000 over 3 years ($150,000 per year, combined direct and indirect costs)
Research Focus Areas: CCR Grants will support outstanding research focused on two important aspects of precision medicine: the development of next generation-targeted therapies and the development of interventions to eliminate breast cancer health disparities. Proposals that are basic, translational, clinical or population sciences and meet at least one focus area listed below will be considered.
- Beyond PARP inhibitors: Next generation breast cancer therapies targeting the genome and epigenome
- Beyond T-Cells: Next generation breast cancer immunotherapy
- Closing the Gap: New, approaches to address multi-level contributors to breast cancer disparities
KEY DATES
Application System Opens: June 13, 2022
Letters of Intent Extension: August 1, 2022, by 1 p.m., Eastern Standard Time
Letters of Intent Decision: August 5, 2022
Full Application Due: October 5, 2022, by 1 p.m., Eastern Standard Time
Award Notification: On or around April 14, 2023
Read the full CCR Grant LOI Announcement for more details here: https://bit.ly/3xmfvcn